DE3684386D1 - Injizierbare halbfeste formulierungen. - Google Patents

Injizierbare halbfeste formulierungen.

Info

Publication number
DE3684386D1
DE3684386D1 DE8686306282T DE3684386T DE3684386D1 DE 3684386 D1 DE3684386 D1 DE 3684386D1 DE 8686306282 T DE8686306282 T DE 8686306282T DE 3684386 T DE3684386 T DE 3684386T DE 3684386 D1 DE3684386 D1 DE 3684386D1
Authority
DE
Germany
Prior art keywords
solid formulations
injectable semi
injectable
semi
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686306282T
Other languages
English (en)
Inventor
Arvind Lavji Thakkar
Roger Garrick Harrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE3684386D1 publication Critical patent/DE3684386D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8686306282T 1985-08-19 1986-08-14 Injizierbare halbfeste formulierungen. Expired - Lifetime DE3684386D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/766,725 US4775659A (en) 1985-08-19 1985-08-19 Injectable semi-solid formulations

Publications (1)

Publication Number Publication Date
DE3684386D1 true DE3684386D1 (de) 1992-04-23

Family

ID=25077329

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686306282T Expired - Lifetime DE3684386D1 (de) 1985-08-19 1986-08-14 Injizierbare halbfeste formulierungen.

Country Status (12)

Country Link
US (1) US4775659A (de)
EP (1) EP0213851B1 (de)
JP (1) JPH0710781B2 (de)
AU (1) AU596806B2 (de)
CA (1) CA1269933A (de)
DE (1) DE3684386D1 (de)
DK (1) DK386986A (de)
IE (1) IE59130B1 (de)
IL (1) IL79683A (de)
NZ (1) NZ217176A (de)
PH (1) PH23476A (de)
ZA (1) ZA866025B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285874C (en) * 1985-08-23 1991-07-09 Thomas Harry Ferguson Injectable sustained release formulation
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
GB8725427D0 (en) * 1987-10-30 1987-12-02 Lilly Industries Ltd Somatotropin formulations
US5179080A (en) * 1989-08-31 1993-01-12 Clinical Homecare, Corp. Formulations containing growth hormone and nutritional supplements, and methods of treating malnutrition in chronic lung disease
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
SE9202128D0 (sv) * 1992-07-09 1992-07-09 Astra Ab Precipitation of one or more active compounds in situ
US5559110A (en) * 1994-03-09 1996-09-24 The Dupont Merck Pharmaceutical Company Pharmaceutical formulations of cyclic urea type compounds
ZA9711731B (en) 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
CA2903020C (en) 2013-02-28 2019-06-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compostions
BR102013008990A2 (pt) * 2013-04-12 2014-12-30 Ouro Fino Participacoes E Empreendimentos S A Composições farmacêuticas compreendendo kisspeptina ou seus derivados
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2493202A (en) * 1946-06-07 1950-01-03 Merck & Co Inc Process of making a fluid oil-beeswax vehicle for the parenteral administration of drugs
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
BE795516A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
EP0140255B1 (de) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Injektionen mit verzögerter Abgabe
DE3340680A1 (de) * 1983-11-10 1985-05-23 Henkel Kgaa Verfahren zur erhoehung der viskositaet von oelen
ES8702440A1 (es) * 1984-10-04 1986-12-16 Monsanto Co Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa.

Also Published As

Publication number Publication date
CA1269933A (en) 1990-06-05
IL79683A0 (en) 1986-11-30
NZ217176A (en) 1989-06-28
IE59130B1 (en) 1994-01-12
EP0213851B1 (de) 1992-03-18
EP0213851A3 (en) 1987-09-02
JPS6245538A (ja) 1987-02-27
AU596806B2 (en) 1990-05-17
US4775659A (en) 1988-10-04
ZA866025B (en) 1988-04-27
AU6119986A (en) 1987-02-26
DK386986D0 (da) 1986-08-14
JPH0710781B2 (ja) 1995-02-08
IL79683A (en) 1990-11-05
EP0213851A2 (de) 1987-03-11
IE862212L (en) 1987-02-19
PH23476A (en) 1989-08-07
DK386986A (da) 1987-02-20

Similar Documents

Publication Publication Date Title
DE3685409D1 (de) Antitumorzusammensetzung.
FI865037A0 (fi) Mikrobicida kompositioner.
DE3668414D1 (de) Antidiarrhoee-zusammensetzungen.
ES2019061B3 (es) Composicion quimiluminiscente.
DE3681140D1 (de) Polyaethylenzusammensetzung.
DE3684564D1 (de) Veterinaere zusammensetzungen.
DE3674593D1 (de) Medizinische zusammensetzung.
DE3684003D1 (de) Propylen-polymer-zusammensetzung.
DE3684626D1 (de) Schmerzstillende zusammensetzung.
DE3684386D1 (de) Injizierbare halbfeste formulierungen.
DE3676008D1 (de) Substituierte di-t-butylphenole.
DE3686740D1 (de) Einkomponenthaertbare zusammensetzung.
DE3672943D1 (de) Korrosionsinhibierte abschreckmittel.
FI864907A (fi) Faella foer gnagare.
FI871055A0 (fi) Taendroer foer projektil.
DE3676586D1 (de) Substituierte di-t-butylphenole.
FI851978A0 (fi) Sulkonstruktion i sportsko.
FI871056A0 (fi) Taendroer foer projektil.
FI852662A0 (fi) Banformningsparti i pappersmaskin.
FR2582908B3 (fr) Compositions stabilisees.
FI851650L (fi) Banformningsparti i pappersmaskin.
DE3667851D1 (de) Verbessertes pyrgeometer.
FI853106A0 (fi) Hoelje foer stenar i kontinuerligt eldade bastuugnar.
NO851544L (no) Frakkefor/benvarmer.
ATE99721T1 (de) Organoton-zusammensetzung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee